Exact Mass: 556.2883474

Exact Mass Matches: 556.2883474

Found 500 metabolites which its exact mass value is equals to given mass value 556.2883474, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cucurbitacin_E

[(E,6R)-6-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

C32H44O8 (556.3036024)

Cucurbitacin E is a cucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at positions 1, 5 and 23. It is a cucurbitacin and a tertiary alpha-hydroxy ketone. Cucurbitacin E is a natural product found in Cucurbita foetidissima, Helicteres angustifolia, and other organisms with data available. A cucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at positions 1, 5 and 23. Cucurbitacin E is a natural compound which from Cucurbitaceae plants. Cucurbitacin E significantly suppresses the activity of the cyclin B1/CDC2 complex. Cucurbitacin E is a natural compound which from Cucurbitaceae plants. Cucurbitacin E significantly suppresses the activity of the cyclin B1/CDC2 complex.

RD4-2174

[(1S,4S,5S,6R,9S,10R,12R,14R)-4-benzoyloxy-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxo-7-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl]methyl benzoate

C34H36O7 (556.2460906)

Ingenol 3,20-dibenzoate is a benzoate ester. Ingenol 3,20-dibenzoate is a potent protein kinase C (PKC) isoform-selective agonist. Ingenol 3,20-dibenzoate induces selective translocation of nPKC-delta, -epsilon, and -theta and PKC-mu from the cytosolic fraction to the particulate fraction and induces morphologically typical apoptosis through de novo synthesis of macromolecules. Ingenol 3,20-dibenzoate increases the IFN-γ production and degranulation by NK cells, especially when NK cells are stimulated by NSCLC cells[1][2]. Ingenol 3,20-dibenzoate is a potent protein kinase C (PKC) isoform-selective agonist. Ingenol 3,20-dibenzoate induces selective translocation of nPKC-delta, -epsilon, and -theta and PKC-mu from the cytosolic fraction to the particulate fraction and induces morphologically typical apoptosis through de novo synthesis of macromolecules. Ingenol 3,20-dibenzoate increases the IFN-γ production and degranulation by NK cells, especially when NK cells are stimulated by NSCLC cells[1][2].

Dipiperamide C

[2,3-bis[(E)-2-(1,3-benzodioxol-5-yl)ethenyl]-4-(pyrrolidine-1-carbonyl)cyclobutyl]-piperidin-1-ylmethanone

C33H36N2O6 (556.2573236000001)

Dipiperamide C is found in herbs and spices. Dipiperamide C is an alkaloid from white pepper, Piper nigrum. Alkaloid from white pepper, Piper nigrum. Dipiperamide C is found in herbs and spices.

Cucurbitacin E

6-{4,13-dihydroxy-1,6,6,11,15-pentamethyl-5,17-dioxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,7-dien-14-yl}-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetic acid

C32H44O8 (556.3036024)

Dronedarone

N-(2-butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl)methanesulfonamide

C31H44N2O5S (556.2970774)

C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Dronedarone (SR 33589), a derivative of amiodarone (HY-14187), is a class III antiarrhythmic agent for the study of atrial fibrillation (AF) and atrial flutter. Dronedarone is a potent blocker of multiple ion currents, including potassium current, sodium current, and L-type calcium current, and exhibits antiadrenergic effects by noncompetitive binding to β-adrenergic receptors. Dronedarone is a substrate for and a moderate inhibitor of CYP3A4[1].

Omadacycline

4,7-Bis(dimethylamino)-9-{[(2,2-dimethylpropyl)amino]methyl}-1,10,11,12a-tetrahydroxy-3,12-dioxo-3,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboximidate

C29H40N4O7 (556.289685)

Pexmetinib

N-[3-Tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-n-[(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-indazol-5-yl]oxy}phenyl)methyl]carbamimidate

C31H33FN6O3 (556.259804)

PA(2:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

[(2R)-3-(acetyloxy)-2-{[(5Z,7R,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O10P (556.2437216)

PA(2:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Resolvin D5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/2:0)

[(2R)-2-(acetyloxy)-3-{[(5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O10P (556.2437216)

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/2:0), in particular, consists of one chain of one Resolvin D5 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Bu-1709E1

6-Deamino-6-hydroxybutirosin A

C21H40N4O13 (556.259175)

Iryantherin G

rel-1-[3-[(1R,2R,3S)-1,4-Bis(4-hydroxyphenyl)-2,3-dimethylbutyl]-2,4,6-trihydroxyphenyl]-3-(4-methoxyphenyl)-1-propanone

C34H36O7 (556.2460906)

Artocommunol CB

C35H40O6 (556.2824740000001)

Roridin E acetate

(+)-Roridin E acetate

Jaspolinaloside

C27H40O12 (556.251964)

Iryantherin H

rel-1-[3-[(1R,2S,3R)-1,4-Bis(4-hydroxyphenyl)-2,3-dimethylbutyl]-2,4,6-trihydroxyphenyl]-3-(4-methoxyphenyl)-1-propanone

C34H36O7 (556.2460906)

Dronedarone

C31H44N2O5S (556.2970774)

PELAK

Pro-Glu-Leu-Ala-Lys

C25H44N6O8 (556.3220464)

(-)-Euphomine

C32H44O8 (556.3036024)

PG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-glycero-3-phospho-(1-sn-glycerol)

C28H45O9P (556.2801049999999)

PI(15:1(9Z)/0:0)

1-(9Z-pentadecenoyl)-glycero-3-phospho-(1-myo-inositol)

C24H45O12P (556.26485)

PI(P-16:0/0:0)

1-(1Z-hexadecenyl)-glycero-3-phospho-(1-myo-inositol)

C25H49O11P (556.3012334)

Dipiperamide C

1-({2,3-bis[(E)-2-(2H-1,3-benzodioxol-5-yl)ethenyl]-4-[(pyrrolidin-1-yl)carbonyl]cyclobutyl}carbonyl)piperidine

C33H36N2O6 (556.2573236000001)

SQMG 16:0

(2S)-1-palmitoyl-3-O-(6-sulfo-a-D-quinovopyranosyl)-glycerol

C25H48O11S (556.2917178)

LPG 22:6

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-glycero-3-phospho-(1-sn-glycerol)

C28H45O9P (556.2801049999999)

LPI 15:1

1-(9Z-pentadecenoyl)-glycero-3-phospho-(1-myo-inositol)

C24H45O12P (556.26485)

LPI O-16:1

1-(1Z-hexadecenyl)-glycero-3-phospho-(1-myo-inositol)

C25H49O11P (556.3012334)

4-methoxyphenyl 2,4,6-tri-o-benzyl-beta-d-galactopyranoside

C34H36O7 (556.2460906)

9,9-Dimethyl-N,N-bis(3-methylphenyl)-N,N-diphenyl-9H-fluorene-2,7-diamine

C41H36N2 (556.2878336)

4-Methoxyphenyl 2,3,6-Tri-O-benzyl-beta-D-galactopyranoside

C34H36O7 (556.2460906)

Omadacycline

C29H40N4O7 (556.289685)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C254 - Anti-Infective Agent > C258 - Antibiotic

1H-1-Benzazepine-1-acetic acid, 3-(((1-((2R)-2-carboxy-4-(1-naphthalenyl)butyl)cyclopentyl)carbonyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (3S)-

C33H36N2O6 (556.2573236000001)

Pexmetinib

C31H33FN6O3 (556.259804)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

Forskoditerpenoside C

C28H44O11 (556.2883474)

A diterpene glycoside that is labd-14-en-11-one substituted by beta-acetoxy group at position 6, an epoxy group between positions 8 and 13, a beta-hydroxy group at position 7 and a beta-D-glucopyranosyloxy group at position 1 (the 1alpha stereoisomer). Isolated from the whole plant of Coleus forskohlii, it shows relaxative effects on isolated guinea pig tracheal spirals in vitro.

Quinidine barbiturate

C32H36N4O5 (556.2685566)

CID 5225086

C34H36O7 (556.2460906)

(4S,4aS,5aR,12aR)-2-carbamoyl-7-(dimethylamino)-4-(dimethylazaniumyl)-9-[(2,2-dimethylpropylamino)methyl]-10,11,12a-trihydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracen-1-olate

C29H40N4O7 (556.289685)

[(E)-6-[(9R,13R,14S,16R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

C32H44O8 (556.3036024)

ELATERIN, ALPHA

C32H44O8 (556.3036024)

Turnagainolide A

C30H44N4O6 (556.3260683999999)

A natural product found in Bacillus sp. RJA2194.

Turnagainolide B

C30H44N4O6 (556.3260683999999)

A natural product found in Bacillus sp. RJA2194.

rel-12-O-(4Z,7Z)-Deca-4,7-dienoylphorbol-13-acetate

C32H44O8 (556.3036024)

A natural product found in Pimelea elongata.

tetradecanoyl-AMP(1-)

C24H39N5O8P- (556.2536124)

4-[(1R)-1-phenoxyethyl]-5-[5-[(1R)-1-phenoxyethyl]-3-(phenylmethyl)-4-triazolyl]-1-(phenylmethyl)triazole

C34H32N6O2 (556.2586612)

N-[(2S,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide

C27H39F3N4O5 (556.28724)

(1R)-N-(2-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-2-(1-oxo-2-phenylethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide

C32H33FN4O4 (556.248571)

(2R,2R,3S,4S,4aR,6R,7aS,8aR,9S,10S,10aS,13S,14S,14aR,15aS,16aR,17aS)-3-(hydroxymethyl)-3,6,9,13,14-pentamethylicosahydro-1H,3H-spiro[furan-2,12-pyrano[3,2-b]pyrano[2,3:6,7]oxepino[2,3:5,6]pyrano[2,3-g]oxocine]-2,4,10-triol

2α-benzoyloxy-9α,10β-diacetoxy-1β,5α,13α-trihydroxy-4(20),11-taxadiene

C31H40O9 (556.2672190000001)

{"Ingredient_id": "HBIN005279","Ingredient_name": "2alpha-benzoyloxy-9alpha,10beta-diacetoxy-1beta,5alpha,13alpha-trihydroxy-4(20),11-taxadiene","Alias": "2\u03b1-benzoyloxy-9\u03b1,10\u03b2-diacetoxy-1\u03b2,5\u03b1,13\u03b1-trihydroxy-4(20),11-taxadiene","Ingredient_formula": "C31H40O9","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)(CC1O)O)OC(=O)C4=CC=CC=C4)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25197;2255","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

artocommunol cb

C35H40O6 (556.2824740000001)

{"Ingredient_id": "HBIN016981","Ingredient_name": "artocommunol cb","Alias": "NA","Ingredient_formula": "C35H40O6","Ingredient_Smile": "CC(=CCCC(=CCC1=C(OC2=C3C=CC(OC3=C(C(=C2C1=O)O)CC=C(C)C)(C)C)C4=C(C=C(C=C4)O)O)C)C","Ingredient_weight": "556.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1811","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "639645","DrugBank_id": "NA"}

(1s,3s,3'r,3as,4s,4''s,5's,5ar,9as,11as)-3-hydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-5'',7,10-trioxo-2,3,4,5,5a,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-4-yl acetate

C32H44O8 (556.3036024)

2-methyl-5-oxooxolan-3-yl 2-[5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-3,9,11,11-tetramethyl-8-oxo-1-oxaspiro[5.5]undec-4-ene-7-carboxylate

C32H44O8 (556.3036024)

6-(furan-3-yl)-13-hydroxy-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-11-en-14-yl 2-methylpropanoate

C31H40O9 (556.2672190000001)

1-{3-[(1r,2s,3r)-1,4-bis(4-hydroxyphenyl)-2,3-dimethylbutyl]-2,4,6-trihydroxyphenyl}-3-(4-methoxyphenyl)propan-1-one

C34H36O7 (556.2460906)

[(2s,3s,4s,5r,6s)-6-[(2r)-3-(hexadecanoyloxy)-2-hydroxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C25H48O11S (556.2917178)

(1r,7e,9s,11e,13r,14s,16r,17s,18r,19s)-17-ethyl-21-hydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-7,11,20-triene-2,5,6-trione

C34H40N2O5 (556.293707)

methyl 2-[(1r,2s,3s)-2-[(1r,5s,6r,7r,7as)-6,7-bis(acetyloxy)-1-(furan-3-yl)-7a-methyl-4-methylidene-2,5,6,7-tetrahydro-1h-inden-5-yl]-3-hydroxy-2,6,6-trimethyl-5-oxocyclohexyl]acetate

C31H40O9 (556.2672190000001)

1-[(1s,2r,3r,4s)-2,3-bis[(1e)-2-(2h-1,3-benzodioxol-5-yl)ethenyl]-4-(pyrrolidine-1-carbonyl)cyclobutanecarbonyl]piperidine

C33H36N2O6 (556.2573236000001)

11-[(benzoyloxy)methyl]-5,6-dihydroxy-3,7,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl benzoate

C34H36O7 (556.2460906)

(1s,3e,6r,7e,9s,11e,13r,14s,16r,17s,18r,19s)-17-ethyl-6,21-dihydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione

(1s,3e,6r,7e,9s,11e,13r,14s,16r,17s,18r,19s)-17-ethyl-6,21-dihydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione

C34H40N2O5 (556.293707)

2-[(2-{[(3-{3,4-dihydroxy-5-[1-(c-hydroxycarbonimidoyl)-2-iminoimidazolidin-4-yl]pentyl}-5-hydroxy-6-methyl-1,2,3,6-tetrahydropyrazin-2-yl)(hydroxy)methylidene]amino}-1-hydroxypropylidene)amino]-3-methylbutanoic acid

2-[(2-{[(3-{3,4-dihydroxy-5-[1-(c-hydroxycarbonimidoyl)-2-iminoimidazolidin-4-yl]pentyl}-5-hydroxy-6-methyl-1,2,3,6-tetrahydropyrazin-2-yl)(hydroxy)methylidene]amino}-1-hydroxypropylidene)amino]-3-methylbutanoic acid

C23H40N8O8 (556.2968960000001)

methyl 6-[(8-hydroxy-2,6-dimethylocta-2,6-dienoyl)oxy]-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C27H40O12 (556.251964)

6-{2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,5ah,9ah,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H44O8 (556.3036024)

(3as,5ar,9r,10ar)-9-(benzoyloxy)-8-[(benzoyloxy)methyl]-1-isopropyl-5a-methyl-6-oxo-2h,3h,4h,5h,9h,10h,10ah-cyclohepta[e]indene-3a-carboxylic acid

C34H36O7 (556.2460906)

(3s,6r,9s,13s,14ar)-9-benzyl-6-ethyl-1,4,7-trihydroxy-3-[(7r)-7-hydroxy-6-oxooctyl]-6,13-dimethyl-3h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

C30H44N4O6 (556.3260683999999)

16-hydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

C28H44O11 (556.2883474)

(1r,3br,4s,5r,5as,7r,9s,9ar,9br,11as)-4,7-bis(acetyloxy)-1-(furan-3-yl)-9-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate

C32H44O8 (556.3036024)

1-{5',13',25'-trimethyl-11',22'-dioxo-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraen-17'-yl}ethyl acetate

C31H40O9 (556.2672190000001)

(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-(acetyloxy)-7,11-dimethyl-6-(6-oxopyran-3-yl)-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-14-yl 1-methyl butanedioate

C31H40O9 (556.2672190000001)

3,10-diethyl-7-hydroxy-2,8,12,16-tetramethyl-9-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-4,17-dioxabicyclo[14.1.0]heptadec-14-ene-5,13-dione

C29H48O10 (556.3247308)

(2r,4s,5r,9r,10r,13r,14s,15s,17r)-9-(furan-3-yl)-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(2r,4s,5r,9r,10r,13r,14s,15s,17r)-9-(furan-3-yl)-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

C31H40O9 (556.2672190000001)

12,14-bis(acetyloxy)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-18-yl acetate

C32H44O8 (556.3036024)

2-(2,4-dihydroxyphenyl)-3-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-8,8-dimethyl-6-(3-methylbut-2-en-1-yl)pyrano[2,3-h]chromen-4-one

C35H40O6 (556.2824740000001)

methyl 2-{2-[6,7-bis(acetyloxy)-1-(furan-3-yl)-7a-methyl-4-methylidene-2,5,6,7-tetrahydro-1h-inden-5-yl]-3-hydroxy-2,6,6-trimethyl-5-oxocyclohexyl}acetate

C31H40O9 (556.2672190000001)

2-[(1-hydroxy-2-{[1-hydroxy-3-(4-hydroxyphenyl)-2-[3-(4-hydroxyphenyl)-n-methyl-2-(methylamino)propanamido]propylidene]amino}-4-methylpentylidene)amino]propanoic acid

C29H40N4O7 (556.289685)

methyl 2-[(1r,2s,3s)-2-[(1s,5s,6r,7r,7as)-6,7-bis(acetyloxy)-1-(furan-3-yl)-7a-methyl-4-methylidene-2,5,6,7-tetrahydro-1h-inden-5-yl]-3-hydroxy-2,6,6-trimethyl-5-oxocyclohexyl]acetate

C31H40O9 (556.2672190000001)

1-{3-[1,4-bis(4-hydroxyphenyl)-2,3-dimethylbutyl]-2,4,6-trihydroxyphenyl}-3-(4-methoxyphenyl)propan-1-one

C34H36O7 (556.2460906)

2-{[(6r)-6-[(1s)-1-[(1s,2r,6s,7r,9r,11s,12s,15r,16s)-6-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-15-yl]ethyl]-4-methyl-2-oxo-5,6-dihydropyran-3-yl]methoxy}propan-2-yl formate

2-{[(6r)-6-[(1s)-1-[(1s,2r,6s,7r,9r,11s,12s,15r,16s)-6-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-15-yl]ethyl]-4-methyl-2-oxo-5,6-dihydropyran-3-yl]methoxy}propan-2-yl formate

C32H44O8 (556.3036024)

methyl (1s,4as,6s,7r,7as)-6-{[(2e,6e)-8-hydroxy-2,6-dimethylocta-2,6-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1s,4as,6s,7r,7as)-6-{[(2e,6e)-8-hydroxy-2,6-dimethylocta-2,6-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C27H40O12 (556.251964)

(4s)-2-hexanoyl-6-[(3-hexanoyl-2,4-dihydroxy-6-methoxyphenyl)methyl]-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

C32H44O8 (556.3036024)

methyl (1s,4as,6s,7r,7as)-6-{[(2e)-6-hydroxy-2,6-dimethylocta-2,7-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1s,4as,6s,7r,7as)-6-{[(2e)-6-hydroxy-2,6-dimethylocta-2,7-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C27H40O12 (556.251964)

methyl (1s,4as,6s,7r,7as)-6-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2e)-6-hydroxy-2,6-dimethylocta-2,7-dienoyl]oxy}methyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1s,4as,6s,7r,7as)-6-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2e)-6-hydroxy-2,6-dimethylocta-2,7-dienoyl]oxy}methyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C27H40O12 (556.251964)

(3s,3ar,4s,6s,6ar,10s,13r,17as)-4-ethyl-1,6,13-trihydroxy-3-[(1r)-1-(1h-indol-3-yl)ethyl]-10,12-dimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,13h-cyclotrideca[d]isoindole-14,17-dione

C34H40N2O5 (556.293707)

(1s,2r,3r,7r,8s,9s,10s,12r,14e,16s)-3,10-diethyl-7-hydroxy-2,8,12,16-tetramethyl-9-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4,17-dioxabicyclo[14.1.0]heptadec-14-ene-5,13-dione

C29H48O10 (556.3247308)

(1r,4s,5s,6r,9s,10s,13r,14r,15r)-5-formyl-6,14-dihydroxy-5,9-dimethyl-14-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

(1r,4s,5s,6r,9s,10s,13r,14r,15r)-5-formyl-6,14-dihydroxy-5,9-dimethyl-14-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

C28H44O11 (556.2883474)

{8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-en-13-yl}methyl 2-aminobenzoate

C30H40N2O8 (556.278452)

4-ethyl-1,6,13-trihydroxy-3-[1-(1h-indol-3-yl)ethyl]-10,12-dimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,13h-cyclotrideca[d]isoindole-14,17-dione

C34H40N2O5 (556.293707)

{6-[3-(hexadecanoyloxy)-2-hydroxypropoxy]-3,4,5-trihydroxyoxan-2-yl}methanesulfonic acid

C25H48O11S (556.2917178)

(1r,2s,3r,4r,4as,8ar)-2-(benzoyloxy)-3-hydroxy-3,4,8,8a-tetramethyl-4-[(1e)-2-(5-oxo-2h-furan-3-yl)ethenyl]-2,4a,5,6-tetrahydro-1h-naphthalen-1-yl benzoate

C34H36O7 (556.2460906)

(1s,2s,6s,7s,9r,11s,13s,14r,15s,16s,17s)-16-hydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

(1s,2s,6s,7s,9r,11s,13s,14r,15s,16s,17s)-16-hydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

C28H44O11 (556.2883474)

(1r)-1-[(1'r,2s,3'r,8'r,12'e,17'r,18'e,20'z,24'r,25's)-5',13',25'-trimethyl-11',22'-dioxo-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraen-17'-yl]ethyl acetate

13-(acetyloxy)-1-hydroxy-8,12-bis(hydroxymethyl)-4,12,15-trimethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl deca-2,4-dienoate

C32H44O8 (556.3036024)

methyl (1s,4as,6s,7r,7as)-6-{[(2e,6s)-6-hydroxy-2,6-dimethylocta-2,7-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1s,4as,6s,7r,7as)-6-{[(2e,6s)-6-hydroxy-2,6-dimethylocta-2,7-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C27H40O12 (556.251964)

6-[19-(acetyloxy)-10-hydroxy-13,14,18,18-tetramethyl-7-oxo-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),9-trien-6-yl]-2-aminohexanoic acid

C31H44N2O7 (556.3148354)

8,9-bis(acetyloxy)-2,6-dihydroxy-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

C31H40O9 (556.2672190000001)

(2s,9r,13s,15s,17s)-16-hydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[(2s,4s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

C28H44O11 (556.2883474)

methyl (4s,5e,6s)-5-ethylidene-4-(2-{[(2e)-6-hydroxy-2,6-dimethylocta-2,7-dien-1-yl]oxy}-2-oxoethyl)-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylate

methyl (4s,5e,6s)-5-ethylidene-4-(2-{[(2e)-6-hydroxy-2,6-dimethylocta-2,7-dien-1-yl]oxy}-2-oxoethyl)-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylate

C27H40O12 (556.251964)

(2r,4s,7r,8s,9s,10s,12r,13r,16r,17s,18r)-16-(acetyloxy)-10-hydroxy-2,9,13,17-tetramethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylic acid

C32H44O8 (556.3036024)

3-ethenyl-5-hydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydronaphtho[2,1-b]pyran-6-yl acetate

C28H44O11 (556.2883474)

(3s,6s,9r,12s,16r)-6-[(2s)-butan-2-yl]-5,8,11,14-tetrahydroxy-3,12-diisopropyl-9-methyl-16-[(1e)-2-phenylethenyl]-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-2-one

C30H44N4O6 (556.3260683999999)

(2s)-2-{[(2s)-1-hydroxy-2-{[(2s)-1-hydroxy-3-(4-hydroxyphenyl)-2-[(2s)-3-(4-hydroxyphenyl)-n-methyl-2-(methylamino)propanamido]propylidene]amino}-4-methylpentylidene]amino}propanoic acid

C29H40N4O7 (556.289685)

(1s,7z,9s,11z,13r,14s,16r,17s,18r,19s)-17-ethyl-21-hydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-7,11,20-triene-2,5,6-trione

C34H40N2O5 (556.293707)

methyl (1s,4as,6s,7r,7as)-6-{[(2e,6z)-8-hydroxy-2,6-dimethylocta-2,6-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1s,4as,6s,7r,7as)-6-{[(2e,6z)-8-hydroxy-2,6-dimethylocta-2,6-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C27H40O12 (556.251964)

(1r,2r,6s,7s,8r,10s,11s,12r,14s,16r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-16-(prop-1-en-2-yl)-14-[(1e,3e)-undeca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-5-one

(1r,2r,6s,7s,8r,10s,11s,12r,14s,16r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-16-(prop-1-en-2-yl)-14-[(1e,3e)-undeca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-5-one

C32H44O8 (556.3036024)

(3s,6s,9r,12s,16s)-6-[(2s)-butan-2-yl]-5,8,11,14-tetrahydroxy-3,12-diisopropyl-9-methyl-16-[(1e)-2-phenylethenyl]-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-2-one

C30H44N4O6 (556.3260683999999)

(1r,2s,5r,6r,10s,13s,14r,16s)-6-(furan-3-yl)-16-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-11-en-14-yl 2-methylpropanoate

(1r,2s,5r,6r,10s,13s,14r,16s)-6-(furan-3-yl)-16-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-11-en-14-yl 2-methylpropanoate

2-{[(2e,4e,6e,8e,10e,12e,14e,16e)-1-hydroxy-2-methyl-17-[(4r,5r)-5-methyl-2-[(1e)-2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl]heptadeca-2,4,6,8,10,12,14,16-octaen-1-ylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

2-{[(2e,4e,6e,8e,10e,12e,14e,16e)-1-hydroxy-2-methyl-17-[(4r,5r)-5-methyl-2-[(1e)-2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl]heptadeca-2,4,6,8,10,12,14,16-octaen-1-ylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

C32H36N4O5 (556.2685566)

1-{3-[(1r,2r,3s)-1,4-bis(4-hydroxyphenyl)-2,3-dimethylbutyl]-2,4,6-trihydroxyphenyl}-3-(4-methoxyphenyl)propan-1-one

C34H36O7 (556.2460906)

1-{2,3-bis[2-(2h-1,3-benzodioxol-5-yl)ethenyl]-4-(pyrrolidine-1-carbonyl)cyclobutanecarbonyl}piperidine

C33H36N2O6 (556.2573236000001)

(3e,6r)-6-[(1r,2r,3as,3bs,5as,9as,9bs,11ar)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,5ah,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H44O8 (556.3036024)

methyl 6-[(6-hydroxy-2,6-dimethylocta-2,7-dienoyl)oxy]-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C27H40O12 (556.251964)

(1s,2r,4s,5r,9r,10r,13r,14s,15s,17r)-9-(furan-3-yl)-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(1s,2r,4s,5r,9r,10r,13r,14s,15s,17r)-9-(furan-3-yl)-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

C31H40O9 (556.2672190000001)

(2s,3as,4ar,6s,8s,8as,9r,10r)-8,9-bis(acetyloxy)-2,6-dihydroxy-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

C31H40O9 (556.2672190000001)

(4s)-2-hexanoyl-6-[(3-hexanoyl-2,6-dihydroxy-4-methoxyphenyl)methyl]-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

C32H44O8 (556.3036024)

(1s,4s,5s,6r,9r,10r,11r,12r,14r)-11-[(benzoyloxy)methyl]-5,6-dihydroxy-3,7,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl benzoate

C34H36O7 (556.2460906)

9-(furan-3-yl)-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

C31H40O9 (556.2672190000001)

methyl (4s,5e,6s)-5-ethylidene-4-(2-{[(2e,6s)-6-hydroxy-2,6-dimethylocta-2,7-dien-1-yl]oxy}-2-oxoethyl)-6-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylate

methyl (4s,5e,6s)-5-ethylidene-4-(2-{[(2e,6s)-6-hydroxy-2,6-dimethylocta-2,7-dien-1-yl]oxy}-2-oxoethyl)-6-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylate

C27H40O12 (556.251964)

(3e,6r)-6-[(1r,2r,3as,3bs,9as,9br,11ar)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H44O8 (556.3036024)